Detailed information for compound 1977286

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 351.79 | Formula: C18H14ClN5O
  • H donors: 1 H acceptors: 5 LogP: 3.71 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Oc1ccc(c(c1)c1nnc2n1c1nc(ccc1nc2C)C1CC1)Cl
  • InChi: 1S/C18H14ClN5O/c1-9-16-22-23-17(12-8-11(25)4-5-13(12)19)24(16)18-15(20-9)7-6-14(21-18)10-2-3-10/h4-8,10,25H,2-3H2,1H3
  • InChiKey: SCPBTWMZLCCZTO-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens phosphodiesterase 2A, cGMP-stimulated Starlite/ChEMBL No references
Homo sapiens phosphodiesterase 10A Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase Get druggable targets OG5_135549 All targets in OG5_135549
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135363 All targets in OG5_135363
Brugia malayi 3'5'-cyclic nucleotide phosphodiesterase family protein Get druggable targets OG5_135549 All targets in OG5_135549
Schistosoma japonicum cGMP-dependent 3',5'-cyclic phosphodiesterase, putative Get druggable targets OG5_135549 All targets in OG5_135549
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135549 All targets in OG5_135549
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic Get druggable targets OG5_135363 All targets in OG5_135363
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_135363 All targets in OG5_135363
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic Get druggable targets OG5_135363 All targets in OG5_135363
Schistosoma japonicum ko:K01120 3',5'-cyclic-nucleotide phosphodiesterase [EC3.1.4.17], putative Get druggable targets OG5_135549 All targets in OG5_135549
Brugia malayi Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative Get druggable targets OG5_135363 All targets in OG5_135363
Schistosoma japonicum cGMP-dependent 3',5'-cyclic phosphodiesterase, putative Get druggable targets OG5_135549 All targets in OG5_135549

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei cAMP-specific phosphodiesterase phosphodiesterase 10A 789 aa 666 aa 30.2 %
Schistosoma mansoni camp/cgmp cyclic nucleotide phosphodiesterase phosphodiesterase 2A, cGMP-stimulated 934 aa 748 aa 27.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0362 0.2077 0.2077
Schistosoma mansoni family M13 unassigned peptidase (M13 family) 0.0242 0.1057 0.345
Schistosoma mansoni hypothetical protein 0.0125 0.007 0.023
Echinococcus multilocularis endothelin converting enzyme 1 0.0479 0.3063 1
Loa Loa (eye worm) hypothetical protein 0.0362 0.2077 0.2077
Brugia malayi Peptidase family M13 containing protein 0.0479 0.3063 0.3063
Loa Loa (eye worm) hypothetical protein 0.0479 0.3063 0.3063
Mycobacterium ulcerans zinc metalloprotease 0.0479 0.3063 0.5
Toxoplasma gondii peptidase family M13 protein 0.0479 0.3063 0.5
Echinococcus granulosus endothelin converting enzyme 1 0.0479 0.3063 1
Loa Loa (eye worm) hypothetical protein 0.0237 0.102 0.102
Loa Loa (eye worm) hypothetical protein 0.0354 0.2006 0.2006
Schistosoma mansoni hypothetical protein 0.0125 0.007 0.023
Loa Loa (eye worm) hypothetical protein 0.0479 0.3063 0.3063
Schistosoma mansoni hypothetical protein 0.0125 0.007 0.023
Loa Loa (eye worm) hypothetical protein 0.0297 0.1529 0.1529
Loa Loa (eye worm) hypothetical protein 0.0354 0.2006 0.2006
Schistosoma mansoni hypothetical protein 0.0125 0.007 0.023
Loa Loa (eye worm) hypothetical protein 0.0354 0.2006 0.2006
Loa Loa (eye worm) angiotensin-converting enzyme family protein 0.1299 1 1
Brugia malayi 3'5'-cyclic nucleotide phosphodiesterase family protein 0.0161 0.0376 0.0376
Schistosoma mansoni family M13 unassigned peptidase (M13 family) 0.0242 0.1057 0.345
Loa Loa (eye worm) peptidase family M13 containing protein 0.0354 0.2006 0.2006
Mycobacterium tuberculosis Probable zinc metalloprotease Zmp1 0.0479 0.3063 0.5
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase 0.0161 0.0376 0.1227
Loa Loa (eye worm) hypothetical protein 0.0362 0.2077 0.2077
Schistosoma mansoni hypothetical protein 0.0125 0.007 0.023
Schistosoma mansoni family M13 unassigned peptidase (M13 family) 0.0125 0.007 0.023
Loa Loa (eye worm) hypothetical protein 0.0479 0.3063 0.3063
Loa Loa (eye worm) hypothetical protein 0.0161 0.0376 0.0376
Loa Loa (eye worm) hypothetical protein 0.0362 0.2077 0.2077
Schistosoma mansoni neprilysin 0.0125 0.007 0.023
Brugia malayi Hypothetical zinc metalloproteinase T16A9.4 0.0479 0.3063 0.3063
Loa Loa (eye worm) hypothetical protein 0.0256 0.1182 0.1182
Schistosoma mansoni family M13 non-peptidase homologue (M13 family) 0.0242 0.1057 0.345
Loa Loa (eye worm) hypothetical protein 0.0354 0.2006 0.2006
Schistosoma mansoni hypothetical protein 0.0125 0.007 0.023
Onchocerca volvulus 0.0237 0.102 0.5
Schistosoma mansoni Nep2 peptidase (M13 family) 0.0242 0.1057 0.345
Mycobacterium leprae probable zinc metalloprotease 0.0479 0.3063 0.5
Brugia malayi Probable 3',5'-cyclic phosphodiesterase C32E12.2, putative 0.0313 0.1663 0.1663
Loa Loa (eye worm) hypothetical protein 0.0362 0.2077 0.2077
Loa Loa (eye worm) hypothetical protein 0.0362 0.2077 0.2077
Schistosoma mansoni neprilysin-2 (M13 family) 0.0242 0.1057 0.345
Schistosoma mansoni family M13 unassigned peptidase (M13 family) 0.0479 0.3063 1
Loa Loa (eye worm) peptidase family M13 containing protein 0.0354 0.2006 0.2006

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 1 nM Fluorescence Polarization Assay BINDINGDB. No reference
IC50 (binding) = 15 nM BindingDB_Patents: Fluorescence Polarization Assay. The inhibition of PDE 2A or 10 enzyme activity was assessed using IMAP-Phosphodiesterase-cAMP fluorescence labeled substrate (Molecular Devices, Order No. R7506), IMAP TR-FRET screening express (Molecular Devices, Order No. R8160, the TR-FRET component will not be used) and PDE 2A or PDE10 protein expressed upon baculovirus infection in SF9 cells. The cells were incubated after infection for ~3 days and protein production was confirmed by Western Blot. The cells were collected by centrifugation and the pellet frozen in liquid nitrogen before it was resuspended in PBS containing 1% Triton X-100 and protease inhibitors. After 45 min incubation on ice, the cell debris was removed by centrifugation (13.000 rpm, 30 min). Since SF 9 cells do not express cAMP hydrolyzing enzymes to a high extent, no further purification of the protein was needed.All reactions were performed in 384 well plates, Perkin Elmer black optiplates and IMAP reaction buffer with 0.1% Tween20 (kit component). ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.